EDOCAL

Early Detection Of CAncer using photonic crystal Lasers

 Coordinatore 2M Engineering Limited 

 Organization address address: SIDNEY STREET 80
city: FOLKSTONE
postcode: CT19 6HQ

contact info
Titolo: Ms.
Nome: Gillian
Cognome: Mimnagh
Email: send email
Telefono: 31 40 2982020
Fax: 31 40 2982164

 Nazionalità Coordinatore United Kingdom [UK]
 Sito del progetto http://www.edocal.eu
 Totale costo 1˙805˙664 €
 EC contributo 1˙448˙715 €
 Programma FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs
 Code Call FP7-SME-2008-1
 Funding Scheme BSG-SME
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-01-01   -   2011-12-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    2M Engineering Limited

 Organization address address: SIDNEY STREET 80
city: FOLKSTONE
postcode: CT19 6HQ

contact info
Titolo: Ms.
Nome: Gillian
Cognome: Mimnagh
Email: send email
Telefono: 31 40 2982020
Fax: 31 40 2982164

UK (FOLKSTONE) coordinator 1˙184˙715.00
2    COMPOUND SEMICONDUCTOR TECHNOLOGIES GLOBAL LIMITED

 Organization address address: "Block 6, West of Scotland Science Park, Maryhill Road"
city: Glasgow
postcode: G20 0SP

contact info
Titolo: Dr.
Nome: Wyn
Cognome: Meredith
Email: send email
Telefono: +44 141 579 3006

UK (Glasgow) participant 102˙000.00
3    TOP-GAN SP ZOO

 Organization address address: UL. SOKOLOWSKA 29/37
city: WARSZAWA
postcode: 01 142

contact info
Titolo: Prof.
Nome: Michal
Cognome: Leszczynski
Email: send email
Telefono: +48 8760310
Fax: +48 22 8760314

PL (WARSZAWA) participant 80˙000.00
4    Academisch Medisch Centrum bij de Universiteit van Amsterdam

 Organization address address: MEIBERGDREEF 9
city: AMSTERDAM
postcode: 1105AZ

contact info
Titolo: Dr.
Nome: Jacques
Cognome: Bergman
Email: send email
Telefono: +31 20 5659087
Fax: +31 20 5669156

NL (AMSTERDAM) participant 41˙000.00
5    Tayside Health Board

 Organization address address: "Kings Cross, Clepington Road"
city: Dundee
postcode: DD3 8EA

contact info
Titolo: Dr.
Nome: Harry
Cognome: Moseley
Email: send email
Telefono: 01382 660111

UK (Dundee) participant 41˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

burden    imaging    cancer    tissue    patient    blue    light    proto    diagnosis    according    patients    detection    give    porphyrin    sensitizer    strategies    billion    health    laser    cancerous    medical    evidence    tool    prevention    world    techniques   

 Obiettivo del progetto (Objective)

'In Europe there are 3 million new cancer cases per year. According to the WHO the burden of cancer can be reduced by systematic and equitable implementation of evidence based strategies for cancer prevention, early detection and management of patients with cancer. 33% of the cancer burden could be reduced if detected early and treated adequately. The WHO concludes that, early diagnosis of cancers could save the developed world an average of €40 billion per year on medical costs and €80 billion per year on realized productivity. The direct savings on medical treatment alone would be more than €10.000 per patient if early detection was possible. Early cancer diagnosis today consists of recognition of some of the ‘early’ signs by the patient themselves or detection from screenings carried out on specific population groups. If something suspicious is found the next step is to perform a blood analysis and/or to look with non-invasive imaging techniques. Current imaging techniques are widely used in diagnostic procedures but they cannot give conclusive evidence of cancer. Today, only a biopsy and the subsequent pathologist’s interpretation can give a definitive diagnosis of cancer and this is not always enough EDOCAL will use a tunable blue laser to selectively excite an accumulated photo sensitizer, called proto-porphyrin. This sensitizer is taken by the patient to enhance contrast between healthy and cancerous tissue. Reflected light is filtered using state of the art ultra narrow photonic crystal technology. Initial studies have shown that it is possible to detect cancerous tissue using blue light in combination with FDA approved sensitizers (ALA-5 and Proto-Porphyrin). This tool will be based on the principle of preferential retention of proto-porphyrin by cancer cells. The purpose of this project is to create a breakthrough tool for early cancer detection by combining state of the art laser and imaging technology with leading medical research.'

Introduzione (Teaser)

Early detection of cancer saves lives, improves quality of life and reduces health care cost. According to the World Health Organisation the burden of cancer can be significantly reduced by implementation of evidence based strategies for prevention, early detection and management of patients with cancer.

Altri progetti dello stesso programma (FP7-SME)

SELFCLEAN (2013)

"Novel Self-cleaning, anti-bacterial coatings, preventing disease transmission on everyday touched surfaces"

Read More  

QUALIFIBRE (2012)

Qualification and Diagnosis of Carbon and Glass Fibre-Reinforced Composites with Non-Destructive Measurement Technologies

Read More  

N-CHITOPACK (2012)

"Sustainable technologies for the production of biodegradable materials based on natural chitin-nanofibrils derived by waste of fish industry, to produce food grade packaging"

Read More